Please provide your email address to receive an email when new articles are posted on . The European and UK markets will have access to the CLAiR technology from Toku. CLAiR assesses cardiovascular ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. One person dies of cardiovascular disease (CVD) every 34 ...
DENVER--(BUSINESS WIRE)--Cleerly, a leader in AI-based cardiovascular imaging, today announced that Cigna will begin covering Cleerly LABS Advanced Plaque Analysis effective October 1, 2025. The ...
Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings Inc. (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced that the Japan Patent Office ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. For many hospitals, it’s a high-stakes scramble to keep ...
Boston Scientific BSX, a prominent global player in cardiovascular technology, is well-positioned to capitalize on the robust expansion of the cardiovascular devices market. According to a ...
Before selecting any clinical treatment or modality, a comprehensive and also unbiased review and understanding of the clinical evidence is critical for the best patient outcomes. Three examples of ...
The emergence of adaptive cardiac devices, especially those that utilise AI, is propelling the wider industry shift towards personalised medicine, according to GlobalData. “The cardiovascular devices ...
SAN DIEGO, CA - March 27, 2026 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), developer of CardioDialysisTM, a medical device that enables continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results